Samsara BioCapital, LLC

CIK 0001744967 · Q2 2026

13F Equity AUM

$1.2B

+18.3% QoQ

Positions

-22 QoQ

AUM Rank

#3,025

Top 24%

Skill Alpha (FF)

-5.0%/yr^ns

No Clear Edge

Rank #7,394 · Top 90%

vs S&P -20.4%/yr (unadj.)

Quarters Tracked

~7 years

Portfolio Concentration

Top 5: 73.0%Top 10: 90.5%Top 20: 98.8%

SRRK31.2%

ALMS14.7%

MLYS13.0%

SEPN8.7%

Unknown5.5%

NGNE4.4%

KLRS4.3%

Unknown3.9%

STRO2.9%

IVA2.0%

Others (14)9.5%

HHI (Herfindahl-Hirschman Index) measures portfolio concentration. Low (<1500) = diversified, Moderate (1500-2500), High (>2500) = concentrated bets.

Sector Allocation

No sector data available.

Position Sizing

Positions: 24Median: 1.09%Avg: 4.17%

0–0.5%

4(1.1%)

0.5–1%

8(5.8%)

1–3%

4(7.5%)

3–5%

3(12.6%)

5%+

5(73.0%)

Count of positions per weight bucket — (%) = combined portfolio weight

Loading summary cards...

Portfolio Overlap

Shared: 0Unique: 24vs 20 funds

0%Low

Fund positions

Consensus CUSIPs

Jaccard similarity of this fund’s portfolio vs the consensus of top 20 funds by AUM. Low (<15%) = contrarian, Moderate (15-40%), High (>40%) = follows the crowd.

Loading overlap analysis...

Position Changes This Quarter

New0Increased0Decreased0Exited0

No position changes this quarter.

Quarter-over-quarter changes compared to prior 13F filing. New = first appearance; Exited = no longer held.

Loading position changes...

Holdings

Loading holdings...